| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |